Concepedia

Mingli Han

MH

Statistics

Publications

24

Citations

1.9K

H-Index

21

Active since

2012

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Chongqing Medical University

Hainan General Hospital

Hainan Medical University

Second Affiliated Hospital of Chongqing Medical University

Mingli Han is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, molecular oncology, and gene expression.

ORCID

Publications per year

2012–2021

24

Publications

24

RETRACTED ARTICLE: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer

Huaying Dong, Jianguo Hu, Kejian Zou et al. · Molecular Cancer · 2019 · 254 citations · Full text

, , +17

Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN

Mingli Han, Manran Liu, Yimeng Wang et al. · PLoS ONE · 2012 · 243 citations · Full text

, , +17

RETRACTED ARTICLE: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

Mingli Han, Yuanting Gu, Pengwei Lu et al. · Molecular Cancer · 2020 · 192 citations · Full text

, , +17

RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway

Dongwei Dou, Xiaoyang Ren, Mingli Han et al. · Frontiers in Immunology · 2020 · 172 citations · Full text

, , +17

RETRACTED ARTICLE: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

Mingli Han, Jianguo Hu, Pengwei Lu et al. · Cell Death and Disease · 2020 · 141 citations · Full text

, , +17

1–5 of 24